Gastroenterology
Volume 137, Issue 6 , Pages 2052-2062 , December 2009

Foxa1 and Foxa2 Control the Differentiation of Goblet and Enteroendocrine L- and D-Cells in Mice

  • Diana Z. Ye
    • ,
  • Klaus H. Kaestner

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Klaus H. Kaestner, PhD, Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania 19104. fax: (215) 573-5892

Received 4 May 2009 ,Accepted 21 August 2009.

References 

  1. Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 2002;21:6338–6347
  2. Naya FJ, Huang HP, Qui Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroDdeficient mice. Genes Dev. 1997;11:2323–2334
  3. Larsson LI, St-Onge L, Hougaard DM, et al. Pax 4 and 6 regulate gastrointestinal endocrine cell development. Mech Dev. 1998;79:153–159
  4. Larsson L, Tingstedt J, Madsen O, et al. The LIM-homeodomain protein Isl-1 segregates with somatostatin but not with gastrin expression during differentiation of somatostatin/gastrin precursor cells. Endocrine. 1995;3:519–524
  5. Lee CS, Kaestner KH. Clinical endocrinology and metabolism (Development of gut endocrine cells). Best Pract Res Clin Endocrinol Metab. 2004;18:453–462
  6. Yang Q, Bermingham NA, Finegold MJ, et al. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294:2155–2158
  7. Lee CS, Brestelli JE, Kaestner KH. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev. 2002;16:1488–1497
  8. Desai S, Loomis Z, Pugh-Bernard A, et al. Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine. Dev Biol. 2008;313:58–66
  9. Gierl MS, Karoulias N, Wende H, et al. The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev. 2006;20:2465–2478
  10. Katz JP, Perreault N, Goldstein BG, et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002;129:2619–2628
  11. Monaghan AP, Kaestner KH, Grau E, et al. Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm. Development. 1993;119:567–578
  12. Besnard V, Wert SE, Hull WM, et al. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns. 2004;5:193–208
  13. Kaestner KH, Hiemisch H, Luckow B, et al. The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics. 1994;20:377–385
  14. Vatamaniuk MZ, Gupta RK, Lantz KA, et al. Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. Diabetes. 2006;55:2730–2736
  15. Behr R, Brestelli J, Fulmer JT, et al. Mild nephrogenic diabetes insipidus caused by Foxa1 deficiency. J Biol Chem. 2004;279:41936–41941
  16. Shih DQ, Navas MA, Kuwajima S, et al. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A. 1999;96:10152–10157
  17. Kaestner KH, Katz J, Liu Y, et al. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 1999;13:495–504
  18. Ang SL, Rossant J. HNF-3 beta is essential for node and notochord formation in mouse development. Cell. 1994;78:561–574
  19. Sasaki H, Hogan BL. HNF-3 beta as a regulator of floor plate development. Cell. 1994;76:103–115
  20. Gao N, White P, Doliba N, et al. Foxa2 controls vesicle docking and insulin secretion in mature beta cells. Cell Metab. 2007;6:267–279
  21. Sund NJ, Vatamaniuk MZ, Casey M, et al. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. Genes Dev. 2001;15:1706–1715
  22. Sund NJ, Ang SL, Sackett SD, et al. Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol Cell Biol. 2000;20:5175–5183
  23. Gao N, LeLay J, Vatamaniuk MZ, et al. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 2008;22:3435–3448
  24. el Marjou F, Janssen KP, Chang BH, et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193
  25. Gupta R, Gao N, Gorski RK, et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 2007;21:756–769
  26. Lee CS, Sund NJ, Bhr R, et al. Foxa2 is required for the differentiation of pancreatic alpha-cells. Dev Biol. 2005;278:484–495
  27. Qi Y, Nie Z, Lee YS, et al. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes. 2006;55:3083–3090
  28. Nagy TR, Clair AL. Precision and accuracy of dual-energy x-ray absorptiometry for determining in vivo body composition of mice. Obes Res. 2000;8:392–398
  29. Friedman JR, Le PP, Peiris TH, et al. Orthogonal analysis of C/EBPbeta targets in vivo during liver proliferation. Proc Natl Acad Sci U S A. 2004;101:12986–12991
  30. Lai E, Prezioso VR, Tao WF, et al. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev. 1991;5:416–427
  31. Hiemisch H, Schutz G, Kaestner KH. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis. EMBO J. 1997;16:3995–4006
  32. van der Sluis M, Vincent A, Bouma J, et al. Forkhead box transcription factors Foxa1 and Foxa2 are important regulators of Muc2 mucin expression in intestinal epithelial cells. Biochem Biophys Res Commun. 2008;369:1108–1113
  33. Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265
  34. Gauthier BR, Schwitzgebel VM, Zaiko M, et al. Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements. Mol Endocrinol. 2002;16:170–183
  35. Skipper M, Lewis J. Getting to the guts of enteroendocrine differentiation. Nat Genet. 2000;24:3–4
  36. Wang M, Drucker DJ. The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem. 1995;270:12646–12652
  37. Hill ME, Asa SL, Drucker DJ. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol. 1999;13:1474–1486
  38. Leonard J, Serup P, Gonzalez G, et al. The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells. Proc Natl Acad Sci U S A. 1992;89:6247–6251
  39. Van der Sluis M, De Koning BA, De Bruijn AC, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117–129
  40. Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295:1726–1729
  41. Bartman AE, Sanderson SJ, Ewing SL, et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999;80:210–218
  42. Sander M, Neubuser A, Kalamaras J, et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997;11:1662–1673
  43. Sharma SK, Leinemann U, Ratke R, et al. Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans. Biochem J. 2005;389:831–841
  44. Gosmain Y, Avril I, Mamin A, et al. Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J Biol Chem. 2007;282:35024–35034
  45. Philippe J, Morel C, Cordier-Bussat M. Islet-specific proteins interact with the insulin-response element of the glucagon gene. J Biol Chem. 1995;270:3039–3045
  46. Ahlgren U, Pfaff SL, Jessell TM, et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature. 1997;385:257–260
  47. Yuan S, Schoenwolf GC. Islet-1 marks the early heart rudiments and is asymmetrically expressed during early rotation of the foregut in the chick embryo. Anat Rec. 2000;260:204–207
  48. Dube PE, Brubaker PL. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab. 2007;293:E460–E465
  49. Liu CD, Aloia T, Adrian TE, et al. Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. Am Surg. 1996;62:232–236
  50. Ho LT, Pu HF, Sheu WJ, et al. Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats. Chin J Physiol. 1987;30:45–53
  51. Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2003;2:999–1017
  52. Lucey MR. Endogenous somatostatin and the gut. Gut. 1986;27:457–467
  53. Aaboe K, Krarup T, Madsbad S, et al. GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab. 2008;10:994–1003
  54. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409–1439
  55. Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999;48:2270–2276
  56. Zhou J, Wang X, Pineyro MA, et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes. 1999;48:2358–2366
  57. Farilla L, Bulotta A, Hirshberg B, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003;144:5149–5158
  58. Buteau J, El-Assaad W, Rhodes CJ, et al. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia. 2004;47:806–815
  59. Miyawaki K, Yamada Y, Yano H, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999;96:14843–14847
  60. Scrocchi LA, Brown TJ, MaClusky N, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996;2:1254–1258
  61. Pederson RA, Satkunarajah M, McIntosh CH, et al. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes. 1998;47:1046–1052

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by a National Institute for Diabetes and Digestive and Kidney Diseases grant R01-DK053839 (K.H.K.).

PII: S0016-5085(09)01549-2

doi: 10.1053/j.gastro.2009.08.059

Gastroenterology
Volume 137, Issue 6 , Pages 2052-2062 , December 2009

Article Tools

* Image Usage & Resolution